The notices it replaced
- Reissues: PA-23-231 PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 2 steps back: PA-22-177 PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 3 steps back: PA-21-260 PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 4 steps back: PA-20-262 PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 5 steps back: PA-19-273 PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
- 6 steps back: PA-18-573 PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Who won it before
508 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $356,265,525 in first-year total cost, median $712,140.
Most frequent study sections
- Special Emphasis Panel[ZRG1 RPHB-Z (10)]45
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]43
- Special Emphasis Panel[ZRG1 SCIL-D (10)]35
- Special Emphasis Panel[ZRG1 CCHI-J (10)]29
- Special Emphasis Panel[ZRG1 RPHB-D (16)]20
Most frequent institutions
- OREGON RES BEHAVIORAL INTERVENTION STRAT15
- MINNESOTA HEALTHSOLUTIONS CORPORATION10
- ISA ASSOCIATES, INC.8
- BARRON ASSOCIATES, INC.6
- FLINT REHABILITATION DEVICES6
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses1R44CA306740-01 | POWIS, GARTH | PHUSIS THERAPEUTICS, INC., CA | $2,085,765 | ZCA1 |
| 2025 | Efficacy of kTMP, a novel non-invasive brain stimulation method, for the treatment of anhedonia patients.1R44MH142142-01 | LABRUNA, LUDOVICA | MAGNETIC TIDES, INC., CA | $1,651,499 | ZMH1 |
| 2025 | Translational development and clinical evaluation of a bioengineered human lung graft for clinical transplantation1R44HL182545-01 | BACCHETTA, MATTHEW DOMINICO'NEILL, JOHN DAVIDSHAVER, CIARA M | XYLYX BIO, INC., NY | $1,515,926 | ZHL1 |
| 2025 | CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer1R44CA310518-01 | BARRON, CHRISTOPHER | EMBIOSYS INC., MA | $1,379,442 | ZRG1 |
| 2025 | Hub4Smell: Advancing Human Olfactory Research through Digital Innovation and Community Engagement1R44DC022498-01 · under PA-23-231 | KEDZIORA, RICHARDLUCAS-SCHNARRE, PATRICIAPARMA, VALENTINA | ESTENDA SOLUTIONS, INC., PA | $1,372,201 | ZRG1 |
| 2025 | Endovascular Suturing Device for Augmentation of Endograft Fixation During Endovascular Repair of Abdominal Aortic Aneurysm to Reduce Reinterventions Due to Endograft Migration or Type 1a Endoleak1R44HL178318-01A1 | STALKER, KENT | VESTECK, INC, PA | $1,364,080 | ZRG1 |
| 2025 | CTO1681 to prevent and mitigate cytokine release syndrome in multiple myeloma patients receiving CAR T-cell therapy1R44CA295189-01A1 | BERTOLINO, ARTHUR P | CYTOAGENTS, INC., PA | $1,313,567 | ZRG1 |
| 2025 | Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place1R44AG097250-01 | CUTLER, TIMOTHYGELLMAN, CHARLESTOMASZEWSKI-FARIAS, SARAH E | HIDO TECHNOLOGIES, INC., CA | $1,240,765 | ZAG1 |
| 2025 | First-in-human clinical trial of proprietary oral gel to treat radiation-induced oral mucositis in cancer patients1R44CA310522-01 | WANG, XIAO-JINGYOUNG, CHRISTIAN | ALLANDER BIOTECHNOLOGIES, INC., CO | $1,233,852 | ZRG1 |
| 2025 | Use of a Novel Toilet Seat to Passively Collect Digital Biomarkers in Assisted Living Settings2R44AG074812-02A1 | KASHYAP, VIKRAM | TOI LABS, INC., CA | $1,210,170 | ZRG1 |
| 2025 | A Phase 2 Trial of Axelopran Plus Pembrolizumab for the First-Line Treatment of Recurrent/Metastatic HNSCC That Is PD-L1 Positive (PD-L1CPS >1)1R44CA306565-01 | JOHNSON, LORIN K | GLYCYX MOR, INC., CA | $1,197,275 | ZCA1 |
| 2025 | Safety and Efficacy Trial of the ColoSeal ICD System for the Treatment of Diverticular Disease Patients1R44DK143876-01 | FONG, KENTON DODYAN | AVERTO MEDICAL INC, CA | $1,192,362 | ZRG1 |
| 2025 | Point of Care maternal milk concentration device optimizing neonatal growth with targeted nutrition support: Establishing clinical evidence of benefit as an alternative to milk sourced fortification2R44HD110306-03 · under PA-23-231 | NELSON, ELIZABETH RANDALL | MOTHER'S MILK IS BEST, INC., MA | $1,175,845 | ZRG1 |
| 2025 | Ultra-fast manufactured CAR-T therapy1R44CA302091-01 | WALD, DAVID | KURE. AI, INC., OH | $1,125,000 | ZRG1 |
| 2025 | A Phase 2 multi-center trial of CD5 CAR T-cell therapy in patients with T-cell lymphoma1R44CA302357-01 | HEIN, SARAH MARIEMAMONKIN, MAKSIM | MARCH BIOSCIENCES INC, TX | $1,124,607 | ZRG1 |
| 2025 | An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer.2R44CA281555-02 | WILLIAMS, WILLIAM VALENTINE | BRIACELL THERAPEUTICS CORP, PA | $1,106,781 | ZRG1 |
| 2025 | Consumer-Therapist-Connector: Increasing Access to Quality Behavioral Healthcare2R44MH132156-02 | KRAUS, DAVID R. | OUTCOME REFERRALS INC, MA | $1,102,380 | ZRG1 |
| 2025 | Kidney Support in Pediatric Patients using an Ultrafiltration Device2R44DK127631-04 | KNUESEL, ROBERT J | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $1,100,003 | ZDK1 |
| 2025 | Clinical validation of NS-0200, a fixed combination drug product for the treatment of hypertension1R44HL182451-01 | FLEMING, GILBERT ALEXANDERZEMEL, MICHAEL B. | NUSIRT SCIENCES, INC., WV | $1,084,359 | ZHL1 |
| 2025 | BREATHE-BRinging Exercise, Asthma Assessments, TeacHing to Everyone2R44HL167405-02 | FLYNN, SHERYL | BLUE MARBLE REHAB, INC., CA | $1,072,906 | ZRG1 |
| 2025 | PreCharge: An Innovative Digital Program to Increase Coping, Resilience, and Health Care Engagement Among Cancer Previvors2R44CA275673-03 | EVERS, KERRY | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $1,051,590 | ZCA1 |
| 2025 | Cervical Cancer Prevention Prebiotic Device2R44CA254543-02A1 | ELLINGTON, JOANNA ELIZABETH | GLYCIOME, LLC, WA | $1,039,382 | ZCA1 |
| 2025 | Preventing major amputations and preserving functional limbs in no option critical limb-threating ischemia patients1R44HL176399-01A1 | DERUBERTIS, BRIANGENOVESE, ELIZABETH ANNESTEELE, JOSEPH RODGERS | AVEERA MEDICAL INC., CA | $1,032,585 | ZRG1 |
| 2025 | In-vivo study of KSP/QRH heptapeptide dimer for detection of biliary intra-epithelial neoplasia1R44DK143865-01 | BRADY, ELAINE | IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC, MI | $1,022,055 | ZRG1 |
| 2025 | Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors1R44CA297977-01 · under PA-23-231 | BECK, SUSAN LGOLD, MELANIE ARIANE | 5 POINT APP, NY | $1,019,587 | ZRG1 |
| 2025 | Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia1R44HL178006-01A1 | ANDEMARIAM, BIREENOVELLI, ENRICO MOMERT, LAUREL | NEW HEALTH SCIENCES, INC., MA | $1,017,232 | ZHL1 |
| 2025 | Improving Neurological Health with Acetylcholine via Neuroplasticity-based Computerized Exercise in Mild Cognitive Impairment (INHANCE-MCI)1R44AG094520-01 | ATTARHA, MOUNADE VILLERS-SIDANI, ETIENNE | POSIT SCIENCE CORPORATION, CA | $1,006,653 | ZRG1 |
| 2025 | Zip-stitch for Laparoscopic Hysterectomy - Clinical Validation2R44HD104539-03 · under PA-23-231 | MAZZUCCO, DAN C | ZSX MEDICAL, LLC, PA | $1,000,000 | ZRG1 |
| 2025 | Development of LNS8801 for cutaneous melanoma patients who cannot tolerate immunotherapy1R44CA297994-01 · under PA-23-231 | GARYANTES, TINA | LINNAEUS THERAPEUTICS INC, NJ | $999,960 | ZRG1 |
| 2025 | NeuroAccess: a Focused Ultrasound System for SonoBiopsy of the Brain1R44CA298351-01A1 | RAMAMURTHY, BHASKAR | CORDANCE MEDICAL, INC., CA | $999,125 | ZRG1 |
| 2025 | Immunomodulatory AVM0703 to bridge Relapsed/Refractory Diffuse Large B-Cell Lymphoma patients to CAR-T cell immunotherapy1R44CA310370-01 | DEISHER, THERESA A | AVM BIOTECHNOLOGY, LLC, WA | $992,425 | ZRG1 |
| 2025 | Virtual Activities of Living for Occupational Rehabilitation2R44HD107718-02 · under PA-23-231 | ADAMS, RICHARD J. | BARRON ASSOCIATES, INC., VA | $925,658 | ZRG1 |
| 2025 | Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Therapeutic1R44CA298498-01A1 | HAVRANEK, KATHERINEPETERS, KATHERINE BUNGER, EVAN CHARLES | NUVOX PHARMA, LLC, AZ | $919,366 | ZCA1 |
| 2025 | The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence1R44EY037603-01 | KINAST, ROBERTMANSBERGER, STEVEN LO'MALLEY, VINCENT | UNIVERSAL ADHERENCE, LLC, OR | $912,573 | ZRG1 |
| 2025 | A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination2R44MH126793-03 · under PA-23-231 | BRUNS, ERIC J.DEROSIER, MELISSA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $866,289 | ZRG1 |
| 2025 | Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patients2R44DK127658-04 | BESSETTE, ANDRE | ECLIPSE ENTEROGENESIS, INC., CA | $856,731 | ZDK1 |
| 2025 | Transforming Mammography With STARLIGHT, Imagine Scientific's Monochromatic X-Ray Imaging System1R44CA302210-01A1 | SILVER, ERIC | IMAGINE SCIENTIFIC, INC., MA | $779,658 | ZCA1 |
| 2025 | Novel Telomere-Targeting Therapy for Advanced Non-Small Cell Lung Cancer1R44CA309843-01 | ZAPOROJAN, VICTOR | MAIA BIOTECHNOLOGY, INC., IL | $770,168 | ZRG1 |
| 2025 | Kids Standing Up: Promoting Independent Mobility in Children with Neuromuscular Conditions with a Standing Wheelchair1R44HD118822-01 | MCCRACKEN, PATRICIA J | OPTIMAL MOBILITY INC, MN | $739,259 | ZRG1 |
| 2025 | Simulation for Environmental Exposure Education (S3E): A Serious Game Platform for Environmental Health Literacy2R44ES034563-02A1 | KLEPEIS, NEIL EDWARDKUHN, TAMARA J. | DFUSION, INC., CA | $737,527 | ZRG1 |
| 2025 | Intervention for Chronic Insufficient Sleep in Young Adult Cancer Patients and Survivors2R44CA254637-02 · under PA-23-231 | GREENBERG, DANIEL JGRONINGER, J. HUNTER | MEDIA REZ, LLC, DC | $734,690 | ZRG1 |
| 2025 | Utilizing Smart Speaker Technology to Deliver Parenting Education Support to Parents of Young Children2R44HD101190-02 · under PA-23-231 | METZLER, CAROL WSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $712,096 | ZRG1 |
| 2025 | A Novel Prosthetic Ankle Joint with Swing Phase Dorsiflexion and Terrain Adaptation1R44HD117546-01 · under PA-23-231 | BARTLETT, HARRISON LOGAN | LITTLE ROOM INNOVATIONS, LLC, MI | $624,165 | ZRG1 |
| 2025 | SleepFlex head and neck exercise program for the treatment of mild to moderate obstructive sleep apnea1R44HL176356-01A1 | KALAYDJIAN, LORIG SIMA | BERENDO SCIENTIFIC, LLC, CA | $583,718 | ZRG1 |
| 2025 | First in Human Clinical Trial of a Contraceptive MPT YASO GEL1R44HD118927-01 | CHAPPELL, CATHERINECHEN, BEATRICE A.JERSE, ANN E.NORTH, BARBARA BESTPARIKH, URVI M.PRINS, GAIL SWEITZEL, MARY B | YASO THERAPEUTICS INC, TX | $545,966 | ZRG1 |
| 2025 | Detecting Absence Seizures Using Hyperventilation In a Home Environment1R44NR021881-01A1 | KUPERMAN, RACHEL | EYSZ, INC., CA | $542,373 | ZDK1 |
| 2025 | Flourish All: Women's Integrated Stress Reduction for Alzheimer's Risk Prevention Using Digital Tools and Biomarker Monitoring1R44AG097057-01 | LEE, JIN | ONE HEALTH STUDIO LLC, CA | $474,092 | ZAG1 |
| 2025 | Unmute's CARE framework: A Novel Approach to Strengthen the Therapeutic Alliance and Reduce Treatment Disparities1R43MH139271-01 · under PA-23-231 | CHANG, DORIS FLEUNG, COLLEEN | UNMUTE ENTERPRISE INC, MA | $461,776 | ZRG1 |
| 2025 | Patient-directed technology for non-pharmacologic management of cancer pain1R43CA302795-01A1 | GREENBERG, DANIEL JGRONINGER, J. HUNTER | MEDIA REZ, LLC, DC | $404,295 | ZRG1 |
| 2025 | Development and Validation of a Scalable, Self-Guided Trauma Wellness App to Expand Access to Trauma-Focused Mental Health Care1R43MH140657-01 | BERENZ, ERIN C | REBOUND HEALTH, INC., CA | $365,506 | ZRG1 |
| 2025 | Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer1R43CA297808-01 · under PA-23-231 | ARNOLD, RENEE J.G | ARNOLD CONSULTANCY AND TECHNOLOGY, LLC, NY | $357,371 | ZRG1 |
| 2025 | Development and validation of patient-ready Callascope for cervical imaging1R43CA302117-01 | CROUCH, BRIANKRIEGER, MARLEE | CALLA HEALTH FOUNDATION, NC | $317,420 | ZRG1 |
| 2025 | New, Non-Invasive (No-Puff, No-Touch), Tonometry Method: Remote photonic IOP biomonitoring using the damping factor of transitional oscillations after terminating its stimulation by a sound wave.1R43EY037593-01 | SOLANO, JOEL M | EYE C BETTER CORP, CA | $315,825 | ZRG1 |
| 2025 | A Specialized Risk-Stratification Platform and Tailored Diabetes Prevention Program for Post-Partum to Reduce Progression to Type 2 Diabetes1R44MD021154-01 | EDDY, MIKA | MALAMA HEALTH, INC., CA | $313,955 | ZMD1 |
| 2025 | Noninvasive therapeutic hypothermia for tinnitus1R43DC022211-01A1 | KING, CURTIS SCOTTSNAPP, HILLARY ANNE | RESTOREAR DEVICES, LLC, MT | $307,962 | ZRG1 |
| 2025 | STEM As I Am: A culturally relevant media-enhanced tool for engaging Black middle school students and their families in STEM1R43MD020230-01 · under PA-23-231 | MARQUEZ, JESSIESMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $306,872 | ZRG1 |
| 2025 | Improving otitis media with effusion diagnosis in the primary care setting with the laser otoscope1R43DC022815-01A1 | BURNS, STEVEN | MSTATT LLC, OH | $306,872 | ZDC1 |
| 2025 | Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle interventions to lose weight and reduce EDC exposure in individuals with overweight/obesity1R43ES037592-01 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $306,871 | ZRG1 |
| 2025 | Wearable Heat Related Injury Risk Analysis (WHERA) system Resubmission1R43OH012965-01A1 · under PA-23-231 | ZHUKOV, DMITRIY V | CHROMOLOGIC, LLC, CA | $306,469 | ZRG1 |
| 2025 | A Unique Body-Powered Terminal Device with Enhanced Grasping Capabilities for Individuals with Upper Limb Loss1R43HD115423-01A1 · under PA-23-231 | BARTLETT, HARRISON LOGAN | LITTLE ROOM INNOVATIONS, LLC, MI | $304,906 | ZRG1 |
| 2025 | Supplying Useful Perimenopause through Post-menopause Online Resources and Tools (SUPPORT): A culturally appropriate CHW training program to support minority women1R43MD018555-01A1 | DOLAN, MARY SFLEMING, MORGAN | KDH RESEARCH AND COMMUNICATION, INC., GA | $303,916 | ZMD1 |
| 2025 | Lowering Economic, Infrastructure, & Physical Barriers with Noninvasive, Wireless Telemedicine Cerebrospinal Fluid Flow Sensing for Pediatric Hydrocephalus Patients in Puerto Rico1R43MD020017-01A1 · under PA-23-231 | SOMERA, ANNA LISA | RHAEOS, INC., IL | $298,772 | ZRG1 |
| 2025 | Member Engagement Application for Personalized Arts-Based Social Prescriptions1R44AT013552-01 | MCDANIEL, DAWN | SOCIALRX INC, GA | $293,920 | ZAT1 |
| 2025 | Spatially transparent binaural beamforming for noise reduction in cochlear implant processors1R43DC023172-01 | SCHAEFER, PHILIP R | VORTANT TECHNOLOGIES, LLC, NC | $293,512 | ZDC1 |
| 2025 | Progressing Bend Health’s Digital Rapid Crisis Support for Adolescents and Caregivers1R44MH139104-01A1 | HUBERTY, JENNIFER LYNNEROOTS, MONIKA DRUMMOND | BEND HEALTH, INC, WI | $291,491 | ZRG1 |
| 2025 | Validating Terra, a device for closed-loop hot-flash cooling relief and sleep improvement1R43AG087901-01A1 · under PA-23-231 | SISON, EMILIO | AMIRA HEALTH INC., CA | $277,391 | ZRG1 |
| 2025 | PEP/PrEP via Pharmacist-Prescribing Implementation (PEPPI)1R44MH142152-01 | NEWLON, JENNY LEIGHRAFIE, SALLY | EMPOWERX, INC., CA | $242,827 | ZMH1 |
| 2024 | Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis2R44AG061985-06 · under PA-23-231 | LEWIS, GEORGE KENNETH | ZETROZ SYSTEMS, LLC, CT | $2,196,474 | ZRG1 |
| 2024 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery2R44HL160434-02 · under PA-22-177 | SEWARD, KIRK | MERCATOR MEDSYSTEMS, INC., CA | $1,636,379 | ZRG1 |
| 2024 | At-home, ultrasonic device for treatment of vulvovaginal atrophy1R44HD115491-01A1 · under PA-23-231 | ROCKWEILER, HOLLY | MADORRA, INC., OR | $1,514,498 | ZRG1 |
| 2024 | Development and commercialization of support tools to promote safety and adoption of pharmacist prescribed contraceptive services.2R44HD110346-02A1 · under PA-23-231 | KUCEK, MARY | OVARYIT, LLC, PA | $1,341,329 | ZRG1 |
| 2024 | Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients1R44HL170779-01A1 · under PA-23-231 | JOHNSTON, KIMBERLY ANNE | INNOVATIVE BIOTHERAPIES, INC., MI | $1,314,026 | ZRG1 |
| 2024 | A Digital Health Technology to Prevent Family Violence and Improve Child Mental Health2R42MH132191-02 · under PA-23-231 | MAURICIO, ANNE MARIEREITER, LISA ANNSTORMSHAK, ELIZABETH A | NORTHWEST PREVENTION SCIENCE INC, OR | $1,257,942 | ZRG1 |
| 2024 | Surgical drape with a releasable acrylic adhesive for atraumatic negative pressure wound therapy1R44EB036280-01 · under PA-23-231 | ROSING, HOWARDWINCHELL, ROBERT JOHN | GLOBAL BIOMEDICAL TECHNOLOGIES, LLC, FL | $1,216,704 | ZRG1 |
| 2024 | SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS2R44HL151025-02A1 · under PA-23-231 | BOIRE, TIMOTHY C | VENOSTENT, INC., TX | $1,212,392 | ZRG1 |
| 2024 | A comprehensive imaging solution for dense breast cancer screening and diagnostics2R44CA261381-02A1 · under PA-23-231 | GHAZI, PEYMON | MALCOVA INC, CA | $1,134,189 | ZRG1 |
| 2024 | Placement Success Predictor: Using Site-Customized Machine Learning Models to Predict the Best Level of Care Placement for Each Child's Behavioral Health Needs2R44MH125486-02A1 · under PA-22-177 | TRUDEAU, KIMBERLEE JEAN | OUTCOME REFERRALS INC, MA | $1,110,421 | ZRG1 |
| 2024 | A Novel Instrument to Address Freezing of Gait in Parkinson's Patients2R44AG074825-02 · under PA-23-231 | CLARK, BRIAN R | BARRON ASSOCIATES, INC., VA | $1,075,644 | ZRG1 |
| 2024 | A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration2R44EY031202-04A1 · under PA-23-231 | BHUIYAN, ALAUDDINSMITH, ROLAND THEODORE | IHEALTHSCREEN, INC., NY | $1,049,010 | ZRG1 |
| 2024 | Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity1R44HL176464-01A1 · under PA-23-231 | DEROSIER, MELISSA E.EPSTEIN, LEONARD HWILFLEY, DENISE ELLA | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $1,044,896 | ZRG1 |
| 2024 | Development of a novel, cost-effective gait training device utilized at home for the neurological patient population1R44HD113451-01A1 · under PA-23-231 | HARTMAN, JULIETAYLOR, BEN | HEALING INNOVATIONS INC, TN | $1,032,031 | ZRG1 |
| 2024 | Hormonal contraceptive Access via Pharmacist-Prescribing Implementation package (HAPPI)2R44DP006691-02 · under PA-23-231 | MEREDITH, ASHLEY HNEWLON, JENNY LEIGHRAFIE, SALLY | EMPOWERX, INC., CA | $1,014,644 | ZRG1 |
| 2024 | A novel digital platform for measurement-based peer supervision of non-specialist providers conducting brief psychological interventions2R44MH130305-02 · under PA-23-231 | HO, Y. XIANLESH, NEAL | DIMAGI, INC., MA | $1,014,530 | ZRG1 |
| 2024 | Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer1R44CA295173-01 · under PA-23-231 | MEDAROVA, ZDRAVKA O | TRANSCODE THERAPEUTICS, INC., MA | $1,011,207 | ZRG1 |
| 2024 | Clinical Trial to Demonstrate Impact of an AI-enabled 3D Ultrasound-based Guidance System in Reducing Arteriovenous Fistula Cannulation Injury and Improving Patient Quality of Life2R44DK131644-03 · under PA-23-231 | COOPER, RANDYKANG, XIN | SONAVEX, INC., MD | $1,000,001 | ZRG1 |
| 2024 | Collagen-based tissue guidance biofabric for treatment of stress urinary incontinence in women2R44HD102241-03 · under PA-23-231 | SHANKAR, SUBBA | COLLAMEDIX INC., OH | $1,000,000 | ZRG1 |
| 2024 | Long-acting PTH for hypoparathyroidism1R44DK138647-01 · under PA-22-177 | HALES, LAURA M | EXTEND BIOSCIENCES, INC., MA | $999,615 | ZRG1 |
| 2024 | A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL1R44DK138619-01 · under PA-22-177 | BAGNALL, MARK | PHENOMIX SCIENCES, LLC, CA | $996,003 | ZRG1 |
| 2024 | CTO1681 to prevent and mitigate cytokine release syndrome in CAR T-cell recipients1R44CA287634-01A1 · under PA-23-231 | BERTOLINO, ARTHUR P | CYTOAGENTS, INC., PA | $994,859 | ZRG1 |
| 2024 | Development and Commercialization of a weight monitoring platform for wheelchair users1R44HD114504-01A1 · under PA-23-231 | PEARLMAN, JONATHAN LSHAABAN, SAMI | NURELM E-BUSINESS SOFTWARE, PA | $987,365 | ZRG1 |
| 2024 | Development, Feasibility, and Acceptability of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical EducationActivities for 3-5 Grade Elementary Students2R44DP006743-02 · under PA-23-231 | JOHNSON-SHELTON, DEBORAHRICCI, JEANETTE | SAAVSUS, INC., OR | $981,512 | ZRG1 |
| 2024 | Digital Aftercare Assessed: An Evaluation of the Pink Cloud Application in Post-Treatment Substance Use Disorder Support.1R44DA061662-01 · under PA-23-231 | LABRIE, JOSEPH W.VARUGHESE, JASON | PINK CLOUD LLC, CA | $980,000 | ZRG1 |
| 2024 | Efficacy of a Virtual Reality Neuroscience-based Therapy for Chronic Low Back Pain2R44NR017575-02A1 · under PA-23-231 | BAEUERLE, TASSILOCEKO, MARTAWAY, AMANDA | COGNIFISENSE, INC., CA | $977,764 | ZRG1 |
| 2024 | Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss2R44DC018760-02A1 · under PA-23-231 | KING, CURTIS SCOTTRAJGURU, SUHRUD M. | RESTOREAR DEVICES, LLC, MT | $970,535 | ZRG1 |
| 2024 | mHealth app for caregiver instruction in manual therapy for chemotherapy-induced peripheral neuropathy2R44CA268678-02A1 · under PA-23-231 | COLLINGE, WILLIAM B.TOFTHAGEN, CINDY | COLLINGE AND ASSOCIATES, OR | $968,308 | ZRG1 |
| 2024 | MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke1R44AG090216-01 · under PA-23-231 | RUSSELL, IAN MILES | FLINT REHABILITATION DEVICES, CA | $950,785 | ZRG1 |
| 2024 | Intervention to Help Orient Men to Excel (IN-HOME): A culturally appropriate CHW training program to reduce minority caregiver burden2R44MD018249-02 · under PA-23-231 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $925,820 | ZRG1 |
| 2024 | Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis1R44AG090114-01 · under PA-23-231 | VALERO, ERIKA | NEUROMUSCULAR DYNAMICS, LLC, CA | $900,209 | ZRG1 |
| 2024 | Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates1R44HD112276-01A1 · under PA-22-177 | ACHARYA, SUCHISMITA | AYUVIS RESEARCH, INC., TX | $895,365 | ZRG1 |
| 2024 | Closed Loop Electrical Muscle Stimulation System (CL-EMS) with improved safety for ICU environment to mitigate ICU Acquired Weakness2R44EB033725-02 · under PA-23-231 | HASSAN, OUSSAMA | HEALTH DISCOVERY LABS LLC, TX | $874,061 | ZRG1 |
| 2024 | Comparison of convection enhanced delivery systems in a randomized controlled clinical study of recurrent Grade 3-4 glioma patients1R44CA295197-01 · under PA-23-231 | ABRAMOV, VASILIY | CREOSALUS, INC., KY | $857,315 | ZRG1 |
| 2024 | Quédate Tranquila: A Mobile, Web-based Stress Management Intervention for Hispanic Women2R44MD017105-02 · under PA-23-231 | RIOS, DEBRA | ISA ASSOCIATES, INC., VA | $842,935 | ZRG1 |
| 2024 | A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy2R44CA268700-02A1 · under PA-23-231 | AUSTIN, DANA E.GELBER, COHAVA | SERPIN PHARMA, LLC, VA | $838,708 | ZRG1 |
| 2024 | Safety and Efficacy Trial of the ColoSeal ICD System for the Treatment of Rectal Cancer Patients1R44CA287615-01A1 · under PA-23-231 | FONG, KENTON DODYAN | SAVAGE MEDICAL, CA | $838,162 | ZRG1 |
| 2024 | IVOS Medical: Intubation, Optimized.2R44HL164325-02 · under PA-23-231 | PUNSALAN, GABRIEL | IVOS MEDICAL, INC., CA | $824,627 | ZRG1 |
| 2024 | Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care2R44DA056259-02 · under PA-22-177 | DENNIS, MICHAEL L.GILES, MICHAEL | SONARA HEALTH INC, TX | $812,322 | ZRG1 |
| 2024 | Walk with Me (WWM) for Perinatal Grief2R44MH126788-02 · under PA-23-231 | CIOFFI, CAMILLE CSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $803,332 | ZRG1 |
| 2024 | A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer following frontline FOLFIRINOX1R44CA295168-01 · under PA-23-231 | SMAGLO, BRANDONVERA, JUAN FERNANDO | MARKER THERAPEUTICS, INC., TX | $674,275 | ZRG1 |
| 2024 | A Phase 1 Study of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-601) Administered to Patients with Relapsed Non-Hodgkin Lymphoma1R44CA291521-01 · under PA-23-231 | VERA, JUAN FERNANDO | MARKER THERAPEUTICS, INC., TX | $665,000 | ZRG1 |
| 2024 | Computer Guided Microwave Liver Ablation1R44CA287803-01 · under PA-22-177 | BORSIC, ANDREA | NE SCIENTIFIC, INC., MA | $603,206 | ZRG1 |
| 2024 | Phase IIB Clinical and Nonclinical Testing of Soft Spring Continence Pessary for Women, in Support of FDA 510(k) Clearance Requirements2R44HD105574-03 · under PA-22-177 | ROBERTS, MELODY ANN | LIV LABS INC., IL | $563,008 | ZRG1 |
| 2024 | Contact Pathway Inhibitor to Prevent Catheter-Related Thrombosis1R44HL170881-01A1 · under PA-23-231 | LORENTZ, CHRISTINA UTUCKER, ERIK IAN | ARONORA, INC., OR | $493,999 | ZRG1 |
| 2024 | A Feasibility and Efficacy Study of NeuroTrainer Cognitive Training in Students With and Without Attention-Related Difficulties1R43MH135599-01A1 · under PA-23-231 | NYQUIST, JEFFSCHWEITZER, JULIE B. | NEUROTRAINER INC, CA | $489,314 | ZRG1 |
| 2024 | Scaling Effective Behavioral Interventions with MPC Avatar-Based Virtual Training2R44HD094406-02A1 · under PA-23-231 | FIRPO-TRIPLETT, REGINA | DFUSION, INC., CA | $474,877 | ZRG1 |
| 2024 | Dialyzing at home with a new model of the Wearable Artificial Kidney1R44DK139891-01 · under PA-23-231 | GURA, VICTOR | WEARABLE ARTIFICIAL ORGANS, INC., CA | $459,824 | ZRG1 |
| 2024 | Development and Evaluation of a Novel Digital Therapeutic for Adults with Post-Traumatic Stress Disorder1R44MH136888-01 · under PA-23-231 | FEUERSTEIN, SETHSIMON, PATRICIA | OUI THERAPEUTICS, INC, CT | $440,092 | ZRG1 |
| 2024 | Clinical development of a colon-targeted butyrate tablet to evaluate effects on cholesterol and trimethyl amine oxide in subjects at risk for cardiovascular disease1R43HL174321-01A1 · under PA-23-231 | SZEWCZYK, JERZY | BIOKIER, INC., NC | $435,882 | ZRG1 |
| 2024 | Development of an In-Home Sensory Training Therapy to Mitigate Falls Risk Among the Elderly1R44AG087868-01 · under PA-23-231 | YOO, HERBERT | SENAPTEC INC., OR | $407,479 | ZRG1 |
| 2024 | Guided group telehealth to deliver evidence-based therapeutic care to Black college students1R43MD020009-01 · under PA-23-231 | TETTERTON, PHD, VERONICA | THE SWEET I AM, PLLC, TX | $406,092 | ZRG1 |
| 2024 | Feasibility, Pilot, and Communication studies towards Translation of Aurie Reusable Catheter System into Clinical Practice.1R44DK139913-01 · under PA-23-231 | PAUL, SOUVIK | CATHBUDDY, INC., NY | $404,988 | ZRG1 |
| 2024 | A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients1R44CA291622-01A1 · under PA-23-231 | SCHULER, AARON DZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC., WA | $400,000 | ZRG1 |
| 2024 | Treating stress and anxiety in individuals with alcohol use disorder (AUD) using a combination of TRPV-1 channel and C-tactile fiber activation with measurement of oxytocin and cortisol levels1R43AA031638-01 · under PA-23-231 | CHABAL, CHARLES | SOOVU LABS INC, WA | $385,000 | ZRG1 |
| 2024 | Optimizing and testing the care.coach avatar as a personalized, engaging and adaptive virtual health assistant for maximizing functional and quality of life outcomes in autistic young adults1R44MH134719-01A1 · under PA-23-231 | KERSSENS, CHANTAL M | CARE.COACH CORPORATION, CA | $361,412 | ZRG1 |
| 2024 | SoleStim Neuromodulation System, a home-use device for the treatment of dysmenorrhea1R43HD115425-01 · under PA-23-231 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $343,510 | ZRG1 |
| 2024 | Bridges: A digital intervention to increase workplace belonging1R43MD019197-01 · under PA-22-177 | EVERS, KERRY | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $324,381 | ZRG1 |
| 2024 | Development of a Virtual Health Care Platform to reduce emergency re-hospitalizations in Heart Failure Patients transitioning from hospital to home1R43HL174224-01A1 · under PA-23-231 | RAKHIT, ASHOK | NUCLEUSRX, INC., NJ | $321,363 | ZRG1 |
| 2024 | Galvanic Vestibular Stimulation to mitigate episodic Vertigo1R43DC021913-01 · under PA-23-231 | HIRSCHMAN, GORDON BMCCASLIN, DEVIN LOCHLAN | VIVONICS, INC., MA | $319,120 | ZRG1 |
| 2024 | A Hybrid Program to Prevent Substance Use Risk among Upper Elementary School Students Using a Positive Youth Development Approach1R44DA061665-01 · under PA-23-231 | WILLIAMS, CHRISTOPHER | NATIONAL HEALTH PROMOTION ASSOCIATES, NY | $305,046 | ZRG1 |
| 2024 | Effective Newborn Community-Outreach Recovery Engagement (ENCORE) - a culturally appropriate professional development course for community health workers1R43MD019206-01 · under PA-22-177 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $297,083 | ZRG1 |
| 2024 | Innovating Technology Solutions for Residents in Supportive Housing Communities with SUD through Community-Engaged Research1R43DA060718-01 · under PA-23-231 | CIOFFI, CAMILLE CSMITH, DAVID RANDOLPHSNOW-HILL, NYSSA | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $295,924 | ZRG1 |
| 2024 | Development and Evaluation of Technology and Safety Supports for Individuals with Intellectual and Developmental Disabilities to Independently Use Driverless and Driver Supported Ridehailing Services1R44HD113503-01A1 · under PA-23-231 | DAVIES, DANIEL K | ABLELINK SMART LIVING TECHNOLOGIES LLC, CO | $295,919 | ZRG1 |
| 2024 | Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients1R43DA060717-01 · under PA-23-231 | ROSLYAKOV, STANISLAV | ADDINEX TECHNOLOGIES, INC., NY | $295,906 | ZRG1 |
| 2024 | Clinical Testing and Refinement of BumptUp®: A mobile health app to increase physical activity and improve obstetric outcomes among pregnant and postpartum women1R43HD115442-01 · under PA-23-231 | TINIUS, RACHEL ANN | BUMPTUP LABS, INC., KY | $295,883 | ZRG1 |
| 2024 | Cogito: A turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics1R43DA060729-01 · under PA-23-231 | GRABINSKI, MICHAEL JOHN | SQUARE2 SYSTEMS, INC., NH | $295,516 | ZRG1 |
| 2024 | BRITE 2.0: A just-in-time adaptive intervention for suicide safety planning in adolescents1R44MH135605-01 · under PA-22-177 | ALLEN, NICHOLAS B | KSANA HEALTH, INC., OR | $295,504 | ZRG1 |
| 2024 | Assist-MH digital technologies to support school mental health care1R43MH138260-01 · under PA-23-231 | DEROSIER, MELISSA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $295,234 | ZRG1 |
| 2024 | OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Experiencing Substance Misuse.1R43DA059979-01A1 · under PA-23-231 | SANSBURY, KELLY BROCK | OUR RELATIONSHIP LLC, FL | $293,467 | ZRG1 |
| 2024 | Mindfulness Meditation and Respiration Biosignal Feedback1R44MH134709-01A1 · under PA-23-231 | CRESWELL, JOHN DAVIDPOLOWITZ, MATHEW | EQUA HEALTH, INC., PA | $291,447 | ZRG1 |
| 2024 | Evidence-based Parent Training for Diverse Families (PTDF)1R44HD106855-01A1 · under PA-23-231 | GOLDBERG, ABBIE ELIZABETHPENNEFATHER, JORDANWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $283,526 | ZRG1 |
| 2024 | SPIRIT Club CBI Pathway: A novel streaming platform for physical activity and wellness promotion for chronic brain injury survivors1R44HD112248-01A1 · under PA-22-177 | CINER, JARED PHILLIP | SPIRIT FIT & HEALTH INC, MD | $275,699 | ZRG1 |
| 2024 | Development of an Environmental Health Literacy Mobile Application to Reduce Toxic Environmental Exposures in Black Communities1R43MD018950-01A1 · under PA-23-231 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $272,365 | ZRG1 |
| 2023 | Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)1R44EY035596-01 · under PA-22-177 | CAMPBELL, JOHN PETERJONAS, KARYN | SILOAM VISION, INC., OR | $1,907,135 | ZRG1 |
| 2023 | The first clinical use of the BiVACOR Total Artificial Heart1R44HL167582-01A1 · under PA-22-177 | TIMMS, DANIEL | BIVACOR, INC., TX | $1,569,477 | ZRG1 |
| 2023 | Advanced Contingency Management System for Reduction of Alcohol Use.1R44AA030948-01 · under PA-22-177 | JOHNSON, RON KIMBERLYMCDONELL, MICHAEL GMCPHERSON, STERLING M | MANAGED HEALTH CONNECTIONS, LLC, WA | $1,398,716 | ZRG1 |
| 2023 | Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleotide Salvage Pathway to Treat Underserved Tumor Types1R44CA281485-01 · under PA-22-177 | SCHULTZ, KENNETH | TRETHERA CORPORATION, CA | $1,349,805 | ZRG1 |
| 2023 | Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter1R44HL169112-01A1 · under PA-22-177 | CURLEY, MICHAEL G | THERMEDICAL, INC., MA | $1,342,339 | ZRG1 |
| 2023 | Development of the Couplet Care Bassinet to support safe implementation of skin-to-skin contact and rooming-in on postnatal units2R44HD097017-02A1 · under PA-22-177 | MCENTYRE, STACIETOMORI, CECILIATULLY, KRISTIN PATRICIA | COUPLET CARE, LLC, NC | $1,341,487 | ZRG1 |
| 2023 | Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment1R44CA281622-01 · under PA-22-177 | HANNA, GABI | LAMASSU BIO INC, NC | $1,304,141 | ZRG1 |
| 2023 | Noninvasive prediction of skin precancer severity using in vivo cellular imaging and deep learning algorithms.1R44CA285138-01 · under PA-22-177 | SANCHEZ, GABRIEL NESTOR | ENSPECTRA HEALTH, INC., CA | $1,291,948 | ZRG1 |
| 2023 | Automated Long-Term Oxygen Therapy Control System2R44HL160356-02A1 · under PA-22-177 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $1,279,500 | ZRG1 |
| 2023 | An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)1R44CA281615-01 · under PA-22-177 | BROWN, DENNIS | KINTARA THERAPEUTICS, INC., CA | $1,254,180 | ZRG1 |
| 2023 | Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants1R44DC020684-01A1 · under PA-22-177 | KOCH, DEAN RMAITRE, NATHALIE | THRIVE NEUROMEDICAL, LLC, OH | $1,191,469 | ZRG1 |
| 2023 | LIGHTSITE IIIB: Clinical Evaluation of Photobiomodulation (PBM) in dry AMD Patients2R44EY025508-04 · under PA-21-260 | TEDFORD, CLARK E | LUMITHERA, INC., WA | $1,169,339 | ZRG1 |
| 2023 | The Development of a Bimodal Walking-Running Prosthetic Foot1R44HD113432-01 · under PA-22-177 | JOHANSSON, JENNIFER LYNNE | LIBERATING TECHNOLOGIES, INC., MA | $1,142,863 | ZRG1 |
| 2023 | Cognitive Behavioral Immersion: A Randomized Control Trial of Peer-Based Coaching in the Metaverse2R44MH132202-02A1 · under PA-22-177 | ROBINSON, NOAH | VERY REAL HELP, LLC, TN | $1,125,395 | ZRG1 |
| 2023 | Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs.1R44DK137730-01 · under PA-22-177 | MEHTA, MANAV | GEL4MED, INC., MA | $1,119,996 | ZRG1 |
| 2023 | Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy1R44DK136492-01A1 · under PA-22-177 | ABDI, SALAHADINKIMLESS, DEBRAWALLACE, MARK S | PURE GREEN PHARMACEUTICALS, INC., MI | $1,118,712 | ZRG1 |
| 2023 | Access-H20: Sensor driven smart faucet to enable and empower independent drinking and grooming for individuals impacted by spinal cord injury2R44HD108061-02 · under PA-22-177 | JENG, HUEIWANG ANNA COOKWADDELL, JOHN STEVEN | NASONI LLC, VA | $1,068,492 | ZRG1 |
| 2023 | SmartAssist™: Adaptive robotic assistance to maximize patient engagement with the Barrett Upper-Extremity Robotic Trainer (Burt)1R44HD109106-01A1 · under PA-22-177 | BLACK-SCHAFFER, RANDIEMCDONALD, CRAIG | BARRETT TECHNOLOGY, LLC, MA | $1,049,104 | ZRG1 |
| 2023 | SIBTime: Media-enhanced Technology for Promoting the Behavioral Health and Family Relationships of Typically Developing Young Siblings2R44MD015947-02 · under PA-22-177 | MARQUEZ, JESSIEMETZLER, CAROL WVADASY, PATRICIA F | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $1,029,677 | ZRG1 |
| 2023 | A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort2R44ES034312-02 · under PA-22-177 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $1,028,322 | ZRG1 |
| 2023 | Development and evaluation of a multi-media training program for elementary school bullying and abuse prevention: radKIDS 2.02R44MD015695-02 · under PA-22-177 | JOHNSON-SHELTON, DEBORAH | SAAVSUS, INC., OR | $1,011,502 | ZRG1 |
| 2023 | R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes1R44DK137649-01 · under PA-22-177 | FANGER, GARYFURLAN FREGUIA, CHRISTIAN | RISE THERAPEUTICS, LLC, MD | $1,000,000 | ZRG1 |
| 2023 | A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis1R44CA288166-01 · under PA-22-177 | ISAACMAN, STEVEN | NANOMETICS, LLC, CA | $1,000,000 | ZRG1 |
| 2023 | 7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors1R44CA285207-01 · under PA-22-177 | LEWIS, LIONEL DAVIDMARATHI, UPENDRASCHARY, WILLIAM | 7 HILLS PHARMA, LLC, TX | $999,200 | ZRG1 |
| 2023 | Bloomer Augmented Garment Platform-Barrier Removal for women in cArdiac rehab (BRA)1R44HL169065-01 · under PA-22-177 | CHONG, ALICIA | BLOOMER HEALTH TECH INC, MA | $998,904 | ZRG1 |
| 2023 | Contact Pathway Inhibitor to Prevent Vascular Access Failure1R44HL167467-01 · under PA-21-260 | LORENTZ, CHRISTINA UTUCKER, ERIK IAN | ARONORA, INC., OR | $998,549 | ZRG1 |
| 2023 | Non-surgical treatment option for pelvic organ prolapse2R44HD097809-04A1 · under PA-22-177 | HANISSIAN, PAUL | REIA, LLC, NH | $994,718 | ZRG1 |
| 2023 | Mindfulness Based Stress Reduction App for African American Caregivers2R44AG071168-02 · under PA-22-177 | ALEXANDER, KARENCARSWELL, STEVEN BERNARD | COG ANALYTICS, LLC, MD | $992,382 | ZRG1 |
| 2023 | A Web-based Digital Health Portal for Practitioners to Improve Clinical Care and Patient Outcomes for Upper-limb Myoelectric Prosthesis Wearers1R44HD110334-01A1 · under PA-22-177 | WRIGHT, ZACHARY | COAPT, LLC, IL | $986,865 | ZRG1 |
| 2023 | Respiratory Oxygen Adherence Monitor for COPD Patients2R44HL147667-02A1 · under PA-22-177 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $939,577 | ZRG1 |
| 2023 | Development of ALM-488 for nerve and ureter visualization during abdominal surgery1R44CA275546-01A1 · under PA-22-177 | BERMAN, BRETT J.WHITNEY, MICHAEL A | ALUME BIOSCIENCES, INC., CA | $937,219 | ZRG1 |
| 2023 | An online professional development course to train CHWs to provide oral health outreach to low-income Black guardians2R44MD016352-02 · under PA-22-177 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $933,473 | ZRG1 |
| 2023 | A conversational agent to support remote care for individuals with substance use disorder2R44DA050218-02 · under PA-22-177 | HO, Y. XIANJACKSON, JONATHAN LEE | DIMAGI, INC., MA | $927,938 | ZRG1 |
| 2023 | Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease2R44AG047722-07 · under PA-21-260 | LEE, HYUN KYU | POSIT SCIENCE CORPORATION, CA | $924,904 | ZRG1 |
| 2023 | Spinal Cord Innovation in Pediatrics to Treat Cerebral Palsy (SCiP Clinical Study)1R44HD112281-01A1 · under PA-22-177 | GAD, PARAG | SPINEX, INC., CA | $924,592 | ZRG1 |
| 2023 | Intuitive Child Safety Seat to Increase Security2R44HD097846-02 · under PA-22-177 | SEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $922,259 | ZRG1 |
| 2023 | Mucoadhesive film for the treatment of vestibulodynia1R44HD112245-01 · under PA-22-177 | BENHABBOUR, SOUMYA RAHIMAGELLER, ELIZABETHGUTHRIE, KATE MJANUSZIEWICZ, RIMA | ANELLEO, INC., NC | $891,877 | ZRG1 |
| 2023 | XCSITE 300: Cloud-Enabled Closed-Loop Transcranial Current Stimulation Device for At-Home Studies2R44MH119872-03 · under PA-22-177 | TOWNSEND, LEAH BISHOP | PULVINAR NEURO LLC, NC | $886,440 | ZRG1 |
| 2023 | Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy (KneeBRIGHT)2R44AG062069-04A1 · under PA-21-260 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $885,288 | ZRG1 |
| 2023 | Amino Acids and Pediatric Hepatic Steatosis1R44DK135312-01A1 · under PA-22-177 | WOLFE, ROBERT R | AMINO COMPANY LLC, THE, DE | $883,007 | ZRG1 |
| 2023 | Regulatory clearance of the Glide Control Strategy for Upper Limb Prostheses2R44HD090811-04A1 · under PA-21-260 | KALIKI, RAHUL REDDY | INFINITE BIOMEDICAL TECHNOLOGIES, LLC, MD | $873,316 | ZRG1 |
| 2023 | Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes2R44MH114763-02A1 · under PA-21-260 | STERNS, ANTHONY | IRX REMINDER, LLC, OH | $871,153 | ZRG1 |
| 2023 | Developing and testing the Opioid Rapid Response System2R44DA053078-02 · under PA-22-177 | CHOI, HYE JEONGHECHT, MICHAEL | REAL PREVENTION, LLC, NJ | $858,761 | ZRG1 |
| 2023 | Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients1R44HL167591-01A1 · under PA-21-260 | GUPTA, DIPANKARSEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $838,636 | ZRG1 |
| 2023 | Novel Post-surgical Incision Management Device to Prevent Ostomy Complications1R44DK131766-01A1 · under PA-21-260 | OBST, ANDREW T | FISTULA SOLUTION CORPORATION, MN | $773,063 | ZRG1 |
| 2023 | GEMINI: Virtual Integrative Medical Group Visits for Managing Chronic Pain1R44AT012302-01A1 · under PA-22-177 | GARDINER, PAULA MARIEHAAS, NIINA M. | BRIGHTOUTCOME INC., IL | $747,191 | ZRG1 |
| 2023 | Transforming Hospitalizations of Autistic Adolescents via a Novel ABA Telehealth Platform1R44MH134706-01 · under PA-22-177 | OBERLEITNER, RONALD | CARING TECHNOLOGIES, INC., ID | $740,782 | ZRG1 |
| 2023 | Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme1R44CA275508-01A1 · under PA-22-177 | MARCUS, STUART | SONALASENSE INC, CA | $694,814 | ZRG1 |
| 2023 | Reducing Hypertension among African American Men: A Mobile Stress Management Intervention to Address Health Disparities2R44MD017106-02 · under PA-22-177 | LEAF, SAMANTHA L. | ISA ASSOCIATES, INC., VA | $693,481 | ZRG1 |
| 2023 | Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant1R44CA285177-01 · under PA-22-177 | ANGELO, LAURA SVERA, JUAN FERNANDO | MARKER THERAPEUTICS, INC., TX | $664,838 | ZRG1 |
| 2023 | Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program2R44DA053081-02 · under PA-22-177 | HALLGREN, KEVIN A.SEIGUER, SEBASTIANTSUI, JUDITH | EMOCHA MOBILE HEALTH, INC., MD | $654,494 | ZRG1 |
| 2023 | ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)1R44HL169085-01 · under PA-22-177 | CREARY, SUSANSEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $642,844 | ZRG1 |
| 2023 | SBIR, Innovative Immersive Technologies for Evidence-Based Violence Prevention among College Students2R44CE003173-02A1 · under PA-22-177 | WILLIAMS, CHRISTOPHER | NATIONAL HEALTH PROMOTION ASSOCIATES, NY | $615,917 | ZRG1 |
| 2023 | Digital Delivery of Evidence-Based Mental Health Content and Mentoring to Adolescents1R44MH134733-01 · under PA-22-177 | PULLMANN, MICHAEL DAVIDROUNDFIELD, KATRINA | APPA HEALTH INC, CA | $558,383 | ZRG1 |
| 2023 | Home Monitoring of Metabolic Disorders1R44HD112243-01 · under PA-22-177 | THOMAS, MARYLAURA LIND | SEQUITUR HEALTH CORP., AZ | $542,100 | ZRG1 |
| 2023 | A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis1R44AG084484-01 · under PA-22-177 | FANGER, GARY | RISE THERAPEUTICS, LLC, MD | $494,488 | ZRG1 |
| 2023 | Advanced CLAD PERG system with minimal patient preparation for clinical settings (Phase II)2R44EY029620-02A1 · under PA-22-177 | TOFT-NIELSEN, JONATHON ANTHONY | JORVEC CORPORATION, FL | $479,128 | ZRG1 |
| 2023 | Development of an empathetic chatbot to monitor perinatal mental health longitudinally1R43MH130293-01A1 · under PA-21-260 | KERPPOLA, MARIANNAMUZIK, MARIA | POISERA, INC., MI | $431,081 | ZRG1 |
| 2023 | Technology Assisted Treatment for Binge Eating Behavior1R43MH132180-01 · under PA-21-260 | KUMAR, SAMEERPETERSON, CAROL B. | HABITAWARE, INC., MN | $420,178 | ZRG1 |
Showing the 200 most recent of 508 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.